Health Care/Hospital

Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 5, 2021 /PRNewswire/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative ...

2021-03-05 04:01 645

Zymo Research Offers Community-Wide SARS-CoV-2 Detection and Variant Tracking with the Environ™ COVID-19 Wastewater Testing Service

IRVINE, Calif., March 4 2021 /PRNewswire/ -- Zymo Research announced today the launch of itsEnviron™ COVID-19 Wastewater Testing Service. This service facilitates daily community-wide monitoring of COVID-19 cases and variants from a single wastewater sample. Daily case estimates and detected SARS...

2021-03-04 14:33 602

MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions

NYON, Switzerland, March 4, 2021 /PRNewswire/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sust...

2021-03-04 09:00 727

Medical expert warns thousands could die from HPV programming interrupted by Covid-19

LONDON, March 4, 2021 /PRNewswire/ -- On HPV Awareness Day, the International Papillomavirus Society is urging women to attend delayed cervical screenings and for all interrupted services to re-start as thousands continue to miss out on vital HPV care, with deadly consequences. The IPVS is also c...

2021-03-04 08:01 681

Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility

WUXI, China, March 3, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that the European Medicines Agency (EMA) has completed a remote Pre-Approval Inspection (PAI) on its drug substance facility ...

2021-03-03 18:23 455

AXA extends holistic wellness platform "AXA BetterMe" to all Employee Benefits customers

HONG KONG, March 3, 2021 /PRNewswire/ -- With COVID vaccination becoming available inHong Kong, many corporates are getting ready to accelerate their business activities again. As a leading Employee Benefits insurer inHong Kong, AXA Hong Kong andMacau has already taken the lead to support its Emp...

2021-03-03 14:15 747

Telemedicine platform HiDoc launches Nectar, a community app dedicated to women's health and wellness

* Following a spike in the number of teleconsultations and enquiries from the women's community during the circuit breaker period, HiDoc created Nectar, a web-based application to inspire a new generation of women to achieve optimal health * Prominent features of the app include Nectar's Ask ...

2021-03-03 10:00 789

Seegene's Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants

* Seegene's new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 minutes * Seegene's proprietary high multiplex technology enables detection of 10 different targets * S. Korean firm to research additional versions of variant diagnostic tests SEOUL, South Korea,...

2021-03-03 09:20 751

e-condLIFE: Cost of human life and business shut down can be minimized with this new prevention technology

* A smarter preventative way to keep family members safe * Peace of mind for staff and customers that the premises are being disinfected 24 hours KUALA LUMPUR, Malaysia, March 3, 2021 /PRNewswire/ -- Since launching inJune 2020, e-condLIFE has been well received and proven to be effective. Dr...

2021-03-03 09:00 861

FWD Group completes investment in BRI Life Indonesia

JAKARTA, Indonesia, March 3, 2021 /PRNewswire/ -- FWD Group ("FWD") today announced that it has completed its investment in a significant minority stake in PT Asuransi BRI Life ("BRI Life"), the life insurance arm of PT Bank Rakyat Indonesia (Persero) Tbk ("BRI"). As part of this investment, BRI ...

2021-03-03 08:25 939

AGC Biologics Announces the Expansion of Their Cell and Gene Therapy Facility in Milan, Italy

SEATTLE, March 3, 2021 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced plans for the expansion of their Cell and Gene Therapy Center of Excellence inMilan, to increase capacities and implement viral vector su...

2021-03-03 08:00 1084

CxSYS Boosts Malaysian Healthcare with Innovative EHR Solutions

KUALA LUMPUR, Malaysia, March 3, 2021 /PRNewswire/ -- Malaysia-based CxSYS, managed by Starsoft Systems Sdn Bhd, is boosting the country's healthcare by providing innovative record management solutions with connectivity to a wide range of medical devices, enabling efficient operations and better ...

2021-03-03 08:00 743

EZZ Life Science Holdings Limited to list on the ASX today following oversubscribed A$6m IPO

SYDNEY, March 3, 2021 /PRNewswire/ -- Australian beauty and wellness product company, EZZ Life Science Holdings Limited is set to list on the Australian Securities Exchange (ASX) today after raisingA$6 million through its successful and oversubscribed Initial Public Offer. EZZ shares are due to ...

2021-03-03 07:52 2203

Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand

MUMBAI, India, March 2, 2021 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its subsidiary, Cipla Gulf FZ LCC ("Cipla Gulf') is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines inAustra...

2021-03-02 22:05 2976

Sunquest Lauded by Frost & Sullivan for Driving Efficiency and Compliance with Its Differentiated Molecular Laboratory Information Management System

Sunquest provides various interoperable products and services that work with each other to improve lab efficiency and results accuracy LONDON, March 2, 2021 /PRNewswire/ -- Based on its recent analysis of the North American laboratory information management systems (LIMS) market for molecular an...

2021-03-02 22:00 732

Ambu Acclaimed by Frost & Sullivan for Its Groundbreaking Single-use Flexible Endoscopes

Ambu's customer-focused innovations and use of advanced technologies help the company address market needs in a wide range of applications SANTA CLARA, Calif., March 2, 2021 /PRNewswire/ -- Based on its recent analysis of the global flexible single-use endoscope market for advanced visualization...

2021-03-02 21:00 642

Cloud-based Enterprise Imaging to Help Expedite Healthcare Providers' Journey of Enabling Better Care

SANTA CLARA, Calif., March 2, 2021 /PRNewswire/ -- Responding to the shift toward value-based care, provider M&A and consolidation, data expansion, and analytics innovations, healthcare providers are accelerating their digital transformation for greater efficiency, automation and access across cl...

2021-03-02 20:03 3856

Global Cord Blood Corporation Announces Receipt of Unsolicited Non-Binding Acquisition Proposal

HONG KONG, March 2, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors (the "...

2021-03-02 20:00 4891

Merck and GPHL Collaborate on Business Innovation and Development in the Greater Bay Area

GUANGZHOU, China, March 2, 2021 /PRNewswire/ -- Merck, a leading science and technology company, today signed a Memorandum of Understanding (MOU) to begin strategic collaboration with Guangzhou Pharmaceutical Holdings Limited (GPHL), China's leading pharmaceutical company. The collaboration aim...

2021-03-02 18:12 1942

Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX® (Sumatriptan Nasal Spray, 20 mg)

MUMBAI, India, March 2, 2021 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the United States Food and Drug...

2021-03-02 16:01 1832
12345 ... 382